Drug
Tl938
Tl938: highest development phase Phase 2, developed by Teligene US. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Teligene US
Trials
| Drug | Phase | Indication |
|---|---|---|
| TL938 Capsules NCT06589830 | Phase 2 | Colorectal Cancer Metastatic |
Latest
No recent events.
Follow Tl938 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.